OSBPL5 and B-cell chronic lymphocytic leukemia: OSBPL5 expression is a prognostic marker for overall survival in the context of mutated immunoglobulin heavy variable (IGHV) gene status (Fig. 5e) and was recently identified as the strongest predictive gene expression marker for time to progression after CLL treatment [76].